RESTON, Va., Nov. 17, 2020 (SEND2PRESS NEWSWIRE) — The CDC has contracted AMI Expeditionary Healthcare LLC (AMI) to provide Commercial COVID-19 Emergency Response Team (C-C19ERT) services. This work includes sample collection, logistics, and quality control metrics to ensure subsequent, high-quality, CLIA laboratory testing.

The C-C19ERT will be deployed as determined by CDC and work either in tandem with or independent of CDC in the collection, processing, shipping, tracking, storage, testing, and reporting of specimens suspected of COVID-19 exposure.

“These services will be critical to ensuring continuity of operations during CDC’s response to the COVID-19 pandemic and we are honored that the CDC has chosen us for this important work,” said Dr. Andrew Walker, Executive Chairman of AMI.

Dr. Walker went on to say, “The unique nature, scope, and complexity of the scientific, technical, expert, operational, and logistical services needed will vary, from site to site, in an effort to support remote COVID-19 sample collection.”

About AMI

AMI Expeditionary Healthcare is nationally and globally distributed. Physician-owned and physician-led, AMI has been providing healthcare solutions for over a decade in some of the most remote, challenging, and under-resourced environments in the world. AMI has delivered countless healthcare solutions and more than 7,000 medical personnel to upwards of 100 clinical and hospital settings on four continents. AMI is headquartered in Reston, Virginia.

CONTACT INFORMATION Dr. Andrew Walker, Founder and Executive Chairman, AMI Expeditionary Healthcare LLC at: 1-703-996-6821 (mobile), 571-375-8366 (office) or

If you would like to learn more about AMI and their services, please visit





*PHOTO link for media:

*Photo caption: Dr. Andrew Walker, Executive Chairman of AMI Expeditionary Healthcare.

NEWS SOURCE: AMI Expeditionary Healthcare LLC

This press release was issued on behalf of the news source (AMI Expeditionary Healthcare LLC) who is solely responsibile for its accuracy, by Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: 65582 APDF-R8.1

© 2020 Send2Press®, a press release and e-marketing service of NEOTROPE®, Calif., USA.

To view the original version, visit:

Disclaimer: This press release content was not created by the Associated Press (AP).

Copyright 2020 Send2Press Newswire


This content was contributed by a user of the site. If you believe this content may be in violation of the terms of use, you may report it.